BioCentury
ARTICLE | Company News

RetroSense Therapeutics ophthalmic, gene/cell therapy news

February 20, 2012 8:00 AM UTC

RetroSense received a $250,000 grant from the Foundation Fighting Blindness to develop a gene therapy technology to ophthalmic indications. Last October, Wayne State University granted the company exc...